News | May 09, 2011

Pioneer of Catheter-Based Aortic Valve Procedures Traces Progress

May 9, 2011 — John Webb, M.D., FSCAI, has traveled the globe teaching fellow physicians how to repair or replace faulty heart valves using minimally invasive techniques. In a keynote Founders’ Lecture delivered at the Society for Cardiovascular Angiography and Interventions (SCAI) 2011 Scientific Sessions last week, he recount the challenges that arose in developing valve therapies that avoid open-chest surgery. Instead, interventional cardiologists use slender tubes, or catheters, that are threaded into the heart through blood vessels.

“When we started, we thought it was very possible that a transcatheter valve procedure could be developed and could be reproducible, but with no experience, nobody really knew for sure,” said Webb, the McCleod Professor of Heart Valve Intervention at the University of British Columbia in Vancouver.

In his Founders’ Lecture, Webb focused primarily on catheter procedures used to implant new aortic valves, the valve that controls the flow of blood from the heart to the rest of the body. He also addressed the development of transcatheter implantation of pulmonary valves (between the heart and lungs) and mitral valves (between the upper and lower chambers on the left side of the heart). In addition, Webb presented advances in catheter techniques for implanting replacement valves inside artificial valves that have failed after open-chest surgery.

The first catheter procedures to treat constricted aortic valves were being performed just as Webb was beginning his training in interventional cardiology. He became interested in how to improve the technique by doing more than just stretching the calcified aortic valve with a balloon. But the idea of an implantable valve was dismissed by skeptics as too far-fetched.

Refining the technique took many years, said Webb, who has since performed or mentored more than a thousand catheter-based aortic valve replacements in 20 countries.

“With time, as each new problem was identified, we were able to take a careful look at it and analyze it and come up with a way of managing these patients so that these complications would be less likely,” he said. “It was really a story of incremental improvements in the technique and patient selection and the device.”

It was not until about 2006 that Webb became convinced that implantation of an aortic valve with a catheter would become a common procedure. Though practical obstacles still exist, he is confident they can be overcome. He continues to welcome cardiovascular teams to the University of British Columbia for intensive training in the procedure.

For more information: www.scai.org

Related Content

Ancora Heart Announces Positive Interim Analysis of AccuCinch Ventricular Repair System for Heart Failure
News | Heart Valve Technology | September 24, 2018
Ancora Heart Inc. announced positive clinical data from the company’s recently expanded U.S. early feasibility study...
Medtronic Announces TAVR Study of Aortic Stenosis Patients With Bicuspid Valves
News | Heart Valve Technology | September 19, 2018
The U.S. Food and Drug Administration (FDA) has approved an investigational device exemption (IDE) to initiate a new...
4C Medical's AltaValve First-in-Human Experience to be Presented at TCT 2018
News | Heart Valve Technology | September 17, 2018
September 17, 2018 — 4C Medical Technologies Inc.
Gore Acquires Pipeline Medical Technologies Inc.
News | Heart Valve Technology | September 06, 2018
W. L. Gore & Associates Inc. (Gore) announced the acquisition of Pipeline Medical Technologies Inc., a privately...
The Edwards Lifesciences Cardioband Tricuspid Valve Reconstruction System received the European CE mark approval in May.

The Edwards Cardioband Tricuspid Valve Reconstruction System received the European CE mark approval in May, becoming the first transcatheter tricuspid repair device to be approved in the world.

Feature | Heart Valve Technology | August 21, 2018 | Jeff Zagoudis
The tricuspid valve has been dubbed “the forgotten valve” by many practitioners in the interventional cardiology spac
Earlier Intervention for Mitral Valve Disease May Lead to Improved Outcomes
News | Heart Valve Technology | July 26, 2018
The number of patients undergoing mitral valve operations are at an all-time high, and new research suggests many...
The Abbott Tendyne transcatheter mitral valve replacement (TMVR) system  is being tested in the SUMMIT Trial.

The Abbott Tendyne transcatheter mitral valve replacement (TMVR) system.

Feature | Heart Valve Technology | July 26, 2018
July 26, 2018 — The pivotal clinical study in the U.S.
A CoreValve TAVR valve seen in a CT scan looking down from the aortic arch into the left ventricle using reconstruction software from TeraRecon.

A CoreValve TAVR valve seen in a CT scan looking down from the aortic arch into the left ventricle using reconstruction software from TeraRecon.

Feature | Heart Valve Technology | July 26, 2018
July 26, 2018 — A new multi-societal expert consensus document has been released that summarizes the position of thes
Abbott Receives FDA Approval for Third-Generation MitraClip Device
Technology | Heart Valve Technology | July 18, 2018
July 18, 2018 — Abbott announced it received approval from the U.S.
Videos | Heart Valve Technology | July 18, 2018
Jonathon Leipsic, M.D., FSCCT, professor of radiology and cardiology at the University of British Columbia, Vancouver
Overlay Init